Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 3,517-3,528 of 4,306
Other study type icon
CompletedNCT00533260

A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine)

This study is completed in the Netherlands. It focuses on Schizophrenia.

Multiple locations, including Almelo
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
Netherlands
Sponsor
AstraZeneca
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT01923025

A PET Study With RO5545965 in Healthy Male Volunteers

This summary needs review. Please check the official study record and contact the research team for details.

In London
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 25 Years to 50 Years
Countries
United Kingdom
Sponsor
Hoffmann-La Roche
Condition
Schizophrenia
Drug study icon
CompletedNCT00796640

A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
TerminatedNCT00508157

Effects of Aripiprazole Versus Other Atypical Antipsychotics for Schizophrenia

This study was terminated in France, in Switzerland, in Belgium, .... It is testing effects of Aripiprazole Versus Other Atypical Antipsychotics for Schizophrenia.

Multiple locations, including Brussels
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
France, Switzerland, Belgium, ...
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Drug study icon
CompletedNCT01209039

A Repeat Dose Positron Emission Tomography Study With GSK1144814

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Harrow
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
GlaxoSmithKline
Condition
Schizophrenia
Drug study icon
CompletedNCT00567710

A Six-week, Parallel Group, Multi-center, Phase II Study

This study is completed in the United States. It focuses on Schizophrenia.

In Irving
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
BioLineRx, Ltd.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.